Classification of cellular therapy and gene therapy (CGT) products:

How regulators are working with industry?

Variations in the regulatory landscape and classification of cellular products across countries poses a major challenge for sponsors. Get insights on how these products are categorized in the US & EU.

Download Now

Article Highlights

  • How are the CGT products categorized
  • How are the regulators working along with the industry through close oversight and scientific advice
  • How are the regulators encouraging the development of cellular therapies to address unmet needs

Classification of cellular therapy and gene therapy (CGT) products:

How regulators are working with industry?

 

Download Now
Download this publication now!

    Please note that by submitting this form, you consent to your personal data being processed in alignment with our Privacy Policy. APCER is committed to ensuring the security and protection of your personal information. Your personal data will be processed for purpose of facilitating your request and may be used for sending you additional marketing and business development-related information about APCER Life Sciences, its affiliates and our services. You can withdraw your consent by writing to us at DPO@apcerls.com.